Axel Haupt

20PUBLICATIONS

27CO-AUTHORS

PharmacogenomicsPharmaceutical delivery technologiesFood properties (incl. characteristics and health benefits)Epigenetics (incl. genome methylation and epigenomics)Behavioural epidemiology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|Jun 02, 2026

Insulin Sensitivity and Beta Cell Function With Macupatide Alone or With Dulaglutide in Type 2 Diabetes: A Phase 1b, Randomised Controlled Trial.

|Jan 21, 2026

Eloralintide, a selective, long-acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept.

Shobha Bhattachar, Lai San Tham, Beth Tidemann-Miller

|Aug 28, 2025

Impact of tirzepatide treatment on participant-reported food craving and food preference: Secondary analyses of a phase 1 randomised controlled trial in people with obesity with dietary restriction.

Sam F Kennedy, Alastair Knights, Eric Ravussin

|Jul 29, 2025

Decreases in circulating ANGPTL3/8 concentrations following retatrutide treatment parallel reductions in serum lipids.

Yi Wen, Deven Lemen, Yanzhu Lin

|Jun 24, 2025

Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial.

Corby K Martin, Owen T Carmichael, Susan Carnell

|Jan 06, 2025

Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis.

Kieren J Mather, Andrea Mari, Govinda Weerakkody

Pageof 4

Frequent Collaborators

Edward Pratt

Tamer Coskun

Zvonko Milicevic

Kieren J Mather

Shweta Urva

Giacomo Ruotolo

Tim Heise

Melissa K Thomas

Deborah A Robins

Michael A Nauck

Frequent Collaborators

Edward Pratt

Tamer Coskun

Zvonko Milicevic

Kieren J Mather